Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC).

Argilés G, Saro J, Segal NH, Melero I, Ros W, Marabelle A, Rodriguez ME, Albanell J, Calvo E, Moreno V, Cleary JM, Eder P, Paz-Ares L, Hurwitz H, Bacac M, Perro M, Bouseida S, Sandoval F, Sabanes Bove D, Sreckovic S, Jamois C, Silva A, Klein C, Umana P, Karanikas V, Tabernero J.

Ann Oncol. 2017 Jun 1;28(suppl_3). doi: 10.1093/annonc/mdx302.003. No abstract available.

PMID:
30052786
2.

CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies.

Bacac M, Colombetti S, Herter S, Sam J, Perro M, Chen S, Bianchi R, Richard M, Schoenle A, Nicolini V, Diggelmann S, Limani F, Schlenker R, Hüsser T, Richter W, Bray-French K, Hinton H, Giusti AM, Freimoser-Grundschober A, Lariviere L, Neumann C, Klein C, Umaña P.

Clin Cancer Res. 2018 May 1. doi: 10.1158/1078-0432.CCR-18-0455. [Epub ahead of print]

PMID:
29716920
3.

Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies.

Grandjean CL, Montalvao F, Celli S, Michonneau D, Breart B, Garcia Z, Perro M, Freytag O, Gerdes CA, Bousso P.

Sci Rep. 2016 Oct 4;6:34382. doi: 10.1038/srep34382.

4.

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.

Bacac M, Fauti T, Sam J, Colombetti S, Weinzierl T, Ouaret D, Bodmer W, Lehmann S, Hofer T, Hosse RJ, Moessner E, Ast O, Bruenker P, Grau-Richards S, Schaller T, Seidl A, Gerdes C, Perro M, Nicolini V, Steinhoff N, Dudal S, Neumann S, von Hirschheydt T, Jaeger C, Saro J, Karanikas V, Klein C, Umaña P.

Clin Cancer Res. 2016 Jul 1;22(13):3286-97. doi: 10.1158/1078-0432.CCR-15-1696. Epub 2016 Feb 9.

5.

VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.

Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, Yethon JA, Farokhzad OC, Langer R, Starnbach MN, von Andrian UH.

Science. 2015 Jun 19;348(6241):aaa8205. doi: 10.1126/science.aaa8205.

6.

RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm.

Pang P, Jin X, Proctor BM, Farley M, Roy N, Chin MS, von Andrian UH, Vollmann E, Perro M, Hoffman RJ, Chung J, Chauhan N, Mistri M, Muslin AJ, Bonventre JV, Siedlecki AM.

Kidney Int. 2015 Apr;87(4):771-83. doi: 10.1038/ki.2014.364. Epub 2014 Dec 3.

7.

Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.

Riol-Blanco L, Ordovas-Montanes J, Perro M, Naval E, Thiriot A, Alvarez D, Paust S, Wood JN, von Andrian UH.

Nature. 2014 Jun 5;510(7503):157-61. doi: 10.1038/nature13199. Epub 2014 Apr 23.

8.

Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisions.

Henrickson SE, Perro M, Loughhead SM, Senman B, Stutte S, Quigley M, Alexe G, Iannacone M, Flynn MP, Omid S, Jesneck JL, Imam S, Mempel TR, Mazo IB, Haining WN, von Andrian UH.

Immunity. 2013 Sep 19;39(3):496-507. doi: 10.1016/j.immuni.2013.08.034.

9.

Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model.

Martini H, Enright V, Perro M, Workman S, Birmelin J, Giorda E, Quinti I, Lougaris V, Baronio M, Warnatz K, Grimbacher B.

Clin Exp Immunol. 2011 Jun;164(3):381-7. doi: 10.1111/j.1365-2249.2011.04377.x. Epub 2011 Apr 13.

10.

Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination.

Pospori C, Xue SA, Holler A, Voisine C, Perro M, King J, Fallah-Arani F, Flutter B, Chakraverty R, Stauss HJ, Morris EC.

Blood. 2011 Jun 23;117(25):6813-24. doi: 10.1182/blood-2010-08-304568. Epub 2011 Mar 29.

11.

Infant colitis--it's in the genes.

Glocker EO, Frede N, Perro M, Sebire N, Elawad M, Shah N, Grimbacher B.

Lancet. 2010 Oct 9;376(9748):1272. doi: 10.1016/S0140-6736(10)61008-2. No abstract available.

PMID:
20934598
12.

Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.

Perro M, Tsang J, Xue SA, Escors D, Cesco-Gaspere M, Pospori C, Gao L, Hart D, Collins M, Stauss H, Morris EC.

Gene Ther. 2010 Jun;17(6):721-32. doi: 10.1038/gt.2010.4. Epub 2010 Feb 18.

PMID:
20164855
13.

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sánchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, Baumann U, Bacchetta R, Hsu AP, Davis JN, Hammarström L, Davies EG, Eren E, Arkwright PD, Moilanen JS, Viemann D, Khan S, Maródi L, Cant AJ, Freeman AF, Puck JM, Holland SM, Grimbacher B.

J Allergy Clin Immunol. 2010 Feb;125(2):424-432.e8. doi: 10.1016/j.jaci.2009.10.059.

14.

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C.

N Engl J Med. 2009 Nov 19;361(21):2033-45. doi: 10.1056/NEJMoa0907206. Epub 2009 Nov 4.

15.

A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein.

Lorenzato A, Olivero M, Perro M, Brière JJ, Rustin P, Di Renzo MF.

Int J Cancer. 2008 Feb 15;122(4):947-51.

16.

WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells.

Stauss HJ, Thomas S, Cesco-Gaspere M, Hart DP, Xue SA, Holler A, King J, Wright G, Perro M, Pospori C, Morris E.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):113-6. Epub 2007 Sep 12. Review.

PMID:
17855129
17.

Monoclonal T-cell receptors: new reagents for cancer therapy.

Stauss HJ, Cesco-Gaspere M, Thomas S, Hart DP, Xue SA, Holler A, Wright G, Perro M, Little AM, Pospori C, King J, Morris EC.

Mol Ther. 2007 Oct;15(10):1744-50. Epub 2007 Jul 17. Review.

18.

An update on the evaluation and management of plantar puncture wounds and Pseudomonas osteomyelitis.

Inaba AS, Zukin DD, Perro M.

Pediatr Emerg Care. 1992 Feb;8(1):38-44. Review.

PMID:
1603689
19.

Dysmorphism leading to a diagnosis of acquired immunodeficiency syndrome.

Perro M.

Am J Dis Child. 1987 May;141(5):474. No abstract available.

PMID:
3578146

Supplemental Content

Support Center